Becker's Spine Review

Becker's July 2020 Spine Review

Issue link: https://beckershealthcare.uberflip.com/i/1273484

Contents of this Issue

Navigation

Page 15 of 31

i-FACTOR is reinventing spinal fusion with a proven 97.3% fusion rate from a 319 patient Level 1 human IDE clinical study. It has an impeccable safety profile that is equivalent to autograft. 1,2 i-FACTOR research translates into dependable patient outcomes, making it the superior choice for your fusions. REFERENCES: 1. Arnold P, Sasso R. et. al. Spine 2016; 41(13): 1075-83. 2. Arnold P, Sasso R. et. al. Neurosurg 2018; 83(3): 377-84. 3. Internal Data Report ML-0626 06/20 Among 100's of Spinal Bone Graft Choices, Why Choose i-FACTOR® Peptide Enhanced Bone Graft? Safe & Predictable, Only Grows Bone Where You Need It 3 The ONLY Spinal Bone Graft Approved for ACDFs Most Cost Effective Drug-Device Combination Product 3 Level 1 Human IDE Study Proving Clinical Efficacy 1,2 Visit info.cerapedics.com/beckers for more information. IDE Study: 12 months

Articles in this issue

Links on this page

view archives of Becker's Spine Review - Becker's July 2020 Spine Review